Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T

Multiple Sclerosis Journal

Volumn 17, Issue 3, 2011, Pages 289-296

  Choi, I Y ^a   Lee, S P ^a   Denney, D R ^b   Lynch, S G ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

chemical shift imaging; glutathione; human brain; in vivo; magnetic resonance; neurodegeneration; oxidative stress; secondary progressive multiple sclerosis

Indexed keywords

GLUTATHIONE;

ADULT; ARTICLE; BRAIN; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FRONTAL CORTEX; HUMAN; MALE; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; PARIETAL CORTEX; PROTEIN BLOOD LEVEL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 79953232727     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510384010     Document Type: Article

References (38)

1. Frischer JM, Bramow S., Dal-Bianco A., et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009 ; 132: 1175-1189.
2. Bakshi R., Thompson AJ, Rocca MA, et al. MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 2008 ; 7: 615-625.
3. Li DK, Held U., Petkau J., et al. MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability. Neurology 2006 ; 66: 1384-1389. (Pubitemid 43739648)
4. Dutta R. and Trapp BD Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 2007 ; 68 (22 Suppl 3). S22 - S31 ; discussion S43-S54.
5. Grassiot B., Desgranges B., Eustache F. and Defer G. Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review. J Neurol 2009 ; 256: 1397-1412.
6. Gonsette RE Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity. J Neurol Sci 2008 ; 274: 48-53.
7. Levine SM and Chakrabarty A. The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann N Y Acad Sci 2004 ; 1012: 252-266. (Pubitemid 38453530)
8. Sherki Y., Melamed E. and Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 2004 ; 251: 261-268. (Pubitemid 38387142)
9. Sayre LM, Moreira PI, Smith MA and Perry G. Metal ions and oxidative protein modification in neurological disease. Ann Ist Super Sanita 2005 ; 41: 143-164. (Pubitemid 43169859)
10. Ferretti G., Bacchetti T., Principi F., et al. Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity. Mult Scler 2005 ; 11: 677-682. (Pubitemid 41685138)
11. Fisher M., Levine PH, Weiner BH, et al. Monocyte and polymorphonuclear leukocyte toxic oxygen metabolite production in multiple sclerosis. Inflammation 1988 ; 12: 123-131.
12. Ferretti G., Bacchetti T., DiLudovico F., et al. Intracellular oxidative activity and respiratory burst of leukocytes isolated from multiple sclerosis patients. Neurochem Int 2006 ; 48: 87-92. (Pubitemid 41832442)
13. Coyle JT and Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993 ; 262: 689-695. (Pubitemid 23350687)
14. Bains JS and Shaw CA Oxidative stress and neurological diseases: Is glutathione depletion a common factor? In: Shaw CA (ed.) Glutathione in the Nervous System. Washington, DC: Taylor & Francis, 1998, pp. 355-384.
15. Reid M. and Jahoor F. Glutathione in disease. Curr Opin Clin Nutr Metab Care 2001 ; 4: 65-71. (Pubitemid 34754482)
16. Benzi G. and Moretti A. Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radic Biol Med 1995 ; 19: 77-101.
17. Lomaestro BM and Malone M. Glutathione in health and disease: pharmacotherapeutic issues. Ann Pharmacother 1995 ; 29: 1263-1273. (Pubitemid 26044866)
18. Harding JJ, Blakytny R. and Ganea E. Glutathione in disease. Biochem Soc Trans 1996 ; 24: 881-884. (Pubitemid 26306318)
19. Bains JS and Shaw CA Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Brain Res Rev 1997 ; 25: 335-358. (Pubitemid 28071452)
20. Trabesinger AH and Boesiger P. Improved selectivity of double quantum coherence filtering for the detection of glutathione in the human brain in vivo. Magn Reson Med 2001 ; 45 (4). 708-710. (Pubitemid 32260094)
21. Choi I-Y. Regional distribution of glutathione in the human brain in vivo. J Neurochem 2003 ; 87 (Suppl. 1): 161.
22. Zhao T., Heberlein K., Jonas C., Jones DP and Hu X. New double quantum coherence filter for localized detection of glutathione in vivo. Magn Reson Med 2006 ; 55: 676-680. (Pubitemid 43352568)
23. Choi I-Y. Unequivocal detection of glutathione in the human brain in vivo using navigated chemical shift imaging of glutathione: Assessment of regional heterogeneity of glutathione. In Proceedings of the International Society of Magnetic Resonance in Medicine, 2004 ; 683.
24. Choi I-Y., Lee S-P., Garwood M., Ugurbil K. and Merkle H. Simple partial volume transceive coils for in vivo 1H MR studies at high magnetic fields. Concepts Magn Reson B: Magn Reson Eng 2007 ; 31B (2). 71-85.
25. Choi I. -Y, Lee S. -P, Merkle H. and Shen J. Single-shot two-echo technique for simultaneous measurement of GABA and creatine in the human brain in vivo. Magn Reson Med 2004 ; 51: 1115-1121. (Pubitemid 38796995)
26. Agren H. and Niklasson F. Creatinine and creatine in CSF: indices of brain energy metabolism in depression Short note. J Neural Transm 1988 ; 74: 55-59.
27. Perry TL and Hansen S. What excitotoxin kills striatal neurons in Huntington's disease? Clues from neurochemical studies. Neurology 1990 ; 40: 20-24. (Pubitemid 20032885)
28. Cooper AJ and Kristal BS Multiple roles of glutathione in the central nervous system. Biol Chem 1997 ; 378: 793-802. (Pubitemid 27388939)
29. Kurtzke JF Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983 ; 33: 1444-1452. (Pubitemid 14237132)
30. Caramanos Z., Narayanan S. and Arnold DL 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review. Brain 2005 ; 128: 2483-2506. (Pubitemid 41552936)
31. Vrenken H., Barkhof F., Uitdehaag BM, Castelijns JA, Polman CH and Pouwels PJ MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter. Magn Reson Med 2005 ; 53: 256-266. (Pubitemid 40171039)
32. Aboul-Enein F., Krssak M., Hoftberger R., Prayer D. and Kristoferitsch W. Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla. PLoS One 2010 ; 5: e11625.
33. Perry TL, Hansen S., Berry K., Mok C. and Lesk D. Free amino acids and related compounds in biopsies of human brain. J Neurochem 1971 ; 18: 521-528.
34. Slivka A., Spina MB and Cohen G. Reduced and oxidized glutathione in human and monkey brain. Neurosci Lett 1987 ; 74: 112-118. (Pubitemid 17229036)
35. Meister A. and Anderson ME Glutathione. Annu Rev Biochem 1983 ; 52: 711-760. (Pubitemid 13030692)
36. Choi I-Y. and Gruetter R. Dynamic or inert metabolism? Turnover of N-acetyl-aspartate and glutathione from [1-13C] D-glucose in the rat brain in vivo. J Neurochem 2004 ; 91: 778-787. (Pubitemid 39507354)
37. Srinivasan R., Ratiney H., Hammond-Rosenbluth KE, Pelletier D. and Nelson SJ MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis. Magn Reson Imaging 2010 ; 29: 163-170.
38. Choi I-Y., Lee S-P., Merkle H and Shen J. In vivo detection of gray and white matter differences in GABA concentration in the human brain. NeuroImage 2006 ; 33: 85-93. (Pubitemid 44419494)